Wells Fargo & Company Bluejay Diagnostics, Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.19 - $0.41 $0 - $1	4 Added 5.71%	74 $0
Q1 2023 May 12, 2023	BUY	$0.38 - $0.87 $0 - $0	1 Added 1.45%	70 $0
Q4 2022 Feb 13, 2023	BUY	$0.34 - $138.99 $0 - $277	2 Added 2.99%	69 $0
Q3 2022 Nov 14, 2022	BUY	$0.83 - $132.53 $1 - $265	2 Added 3.08%	67 $0
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.63 $6 - $11	7 Added 12.07%	65 $0
Q1 2022 May 16, 2022	BUY	$0.86 - $2.92 $38 - $131	45 Added 346.15%	58 $0
Q4 2021 Feb 14, 2022	BUY	$2.33 - $5.32 $30 - $69	13 New	13 $0

Ticker BJDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,152,300
Market Cap $3.63M
Description
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.